Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tachosil for Prevention of Symptomatic Pelvic Lymphoceles After Pelvic Lymphadenectomy in Gynecologic Malignancies
2011-003115-34Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil in endometrial cancer (EC), Cervical Cancer (CC), sponsored by Medical University of Vienna. Started May 2012; status: completed.
02
Drugs
tachosil
03
Conditions
endometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on 2011-003115-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003115-34.